These names are well-positioned to benefit from the changing media landscape.
ViacomCBS offers solid upside potential with only modest downside risk based on the company's characteristics.
As we head into 2020, the technical picture is best described as something's gotta give.
My caution perhaps stems from what for the most part appears to be rampant success in 2019 that leaves a high bar for 2020.
Stemline Therapeutics, Entercom Communications and Ocular Therapeutix offer reasons to think their shares will perform better in the New Year.
The charts and indicators of the entertainment giant present a bullish case,
Prices have trended higher for a year and are now retesting highs from July.
Its shares look extended on a short-term basis, so traders should wait for a shallow dip or some sideways price action before returning to the long side.
The upside potential of the merged media giant is even greater than an initial working of the numbers suggested.
The streaming giant is both pricing its services aggressively in India and spending heavily on local content. But there's a method to its madness.